KOPS - The Institutional Repository of the University of Konstanz

Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation

Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation

Cite This

Files in this item

Files Size Format View

There are no files associated with this item.

CHOVANCOVA, Petra, Ludmilla EFREMOVA, Simon GUTBIER, Stefan SCHILDKNECHT, Marcel LEIST, 2016. Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation. In: Naunyn-Schmiedeberg's Archives of Pharmacology. Springer. 389(Suppl 1), pp. S3. ISSN 0028-1298. eISSN 1432-1912. Available under: doi: 10.1007/s00210-016-1213-y

@article{Chovancova2016Switc-52683, title={Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation}, year={2016}, doi={10.1007/s00210-016-1213-y}, number={Suppl 1}, volume={389}, issn={0028-1298}, journal={Naunyn-Schmiedeberg's Archives of Pharmacology}, author={Chovancova, Petra and Efremova, Ludmilla and Gutbier, Simon and Schildknecht, Stefan and Leist, Marcel}, note={Meeting Abstract} }

Background: Astrocytes are the largest cell population in the human brain, and they react to injury and cytokines with activation. Only few experimental studies have examined the interaction of activated astrocytes with human neurons and the pharmacology thereof.<br />Experimental approach: Immortalized murine astrocytes (IMA) were combined with human LUHMES neurons, and stimulated with an inflammatory (TNF, IL-1) cytokine mix (CM). Neuronal survival was studied both in co-cultures and in monocultures after transfer of conditioned medium from activated IMA. Interventions with >20 pharmaceutical compounds were used to profile the model system.<br />Key results: Control IMA supported neurons, and protected them from neurotoxicants. Inflammatory activation reduced this protection, and prolonged exposure of co-cultures to CM triggered neurotoxicity. This neither involved direct effects of cytokines on neurons, nor secretion of nitric oxide from astrocytes, but it was prevented by the corticosteroid dexamethasone. The neurotoxicity-mediating effect of IMA was faithfully reproduced by human astrocytes. Moreover, glia-dependent toxicity was also observed, when IMA cultures were stimulated with CM, and the culture medium was transferred to neurons. Such neurotoxicity was prevented when astrocytes were treated by p38 kinase inhibitors or dexamethasone, whereas such compounds had no effect, when added to neurons. Conversely, treatment of neurons with five different drugs, including resveratrol and CEP1347, prevented toxicity of astrocyte supernatants.<br />Conclusion: The sequential IMA-LUHMES neuroinflammation model is suitable for separate profiling of both glial-directed and directly neuroprotective strategies. Moreover, direct evaluation in co-cultures of the same cells allows for testing of therapeutic effectiveness in more complex settings, in which astrocytes affect pharmacological properties of neurons. Chovancova, Petra 2021-02-03T07:37:58Z Schildknecht, Stefan Efremova, Ludmilla Gutbier, Simon eng 2021-02-03T07:37:58Z Switching from astrocytic neuroprotection to neurodegeneration by cytokine stimulation 2016 Efremova, Ludmilla Chovancova, Petra Gutbier, Simon Leist, Marcel Schildknecht, Stefan Leist, Marcel terms-of-use

This item appears in the following Collection(s)

Search KOPS


Browse

My Account